Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-09 4:31 pm Purchase | 2021-11-29 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 3,503,419 5.300% | 3,503,419 (New Position) | Filing History |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | Bolt Biotherapeutics, Inc. BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 111,513 6.000% | 111,513 (New Position) | Filing History |
| 2021-10-15 4:49 pm Purchase | 2021-10-05 | 13G | Gemini Therapeutics, Inc. GMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 223,284 5.200% | 223,284 (New Position) | Filing History |
| 2021-09-17 4:54 pm Purchase | 2021-09-07 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,296,452 5.300% | 1,296,452 (New Position) | Filing History |
| 2021-08-20 4:36 pm Purchase | 2021-08-10 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,052,358 5.600% | 2,052,358 (New Position) | Filing History |
| 2021-08-10 5:05 pm Purchase | 2021-08-04 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 1,796,918 5.500% | 1,796,918 (New Position) | Filing History |
| 2021-07-30 4:42 pm Purchase | 2021-07-20 | 13G | Cano Health, Inc. CANO | SUVRETTA CAPITAL MANAGEMENT LLC | 87,089 5.100% | 87,089 (New Position) | Filing History |
| 2021-07-26 5:21 pm Purchase | 2021-07-14 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 1,595,164 5.600% | 1,595,164 (New Position) | Filing History |
| 2021-05-07 4:46 pm Purchase | 2021-04-28 | 13G | Benitec Biopharma Inc. BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 45,235 9.800% | 45,235 (New Position) | Filing History |
| 2021-04-23 4:30 pm Purchase | 2021-04-14 | 13G | Fintech Acquisition Corp. V FTCV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,901,890 7.400% | 1,901,890 (New Position) | Filing History |
| 2021-04-22 4:02 pm Purchase | 2021-04-12 | 13G | Otonomy, Inc. OTIC | SUVRETTA CAPITAL MANAGEMENT LLC | 6,018,878 9.990% | 6,018,878 (New Position) | Filing History |
| 2021-04-02 10:59 am Purchase | 2021-03-23 | 13G | Therapeutics Acquisition Corp. RACA | SUVRETTA CAPITAL MANAGEMENT LLC | 1,095,400 7.800% | 1,095,400 (New Position) | Filing History |
| 2021-03-29 4:35 pm Purchase | 2021-03-19 | 13G | Solid Biosciences Inc. SLDB | SUVRETTA CAPITAL MANAGEMENT LLC | 398,280 5.400% | 398,280 (New Position) | Filing History |
| 2021-03-08 4:57 pm Purchase | 2021-02-25 | 13G | InflaRx N.V. IFRX | SUVRETTA CAPITAL MANAGEMENT LLC | 6,285,000 13.600% | 6,285,000 (New Position) | Filing History |
| 2021-03-01 4:54 pm Purchase | 2021-02-24 | 13G | Revolution Acceleration Acquisition Corp RAAC | SUVRETTA CAPITAL MANAGEMENT LLC | 2,450,000 8.500% | 2,450,000 (New Position) | Filing History |
| 2021-02-26 4:24 pm Purchase | 2021-02-17 | 13G | Sio Gene Therapies Inc. SIOX | SUVRETTA CAPITAL MANAGEMENT LLC | 5,489,000 8.600% | 5,489,000 (New Position) | Filing History |
| 2021-02-19 4:27 pm Purchase | 2021-02-10 | 13G | Mereo BioPharma Group plc MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 31,827,500 5.900% | 31,827,500 (New Position) | Filing History |
| 2021-02-16 4:21 pm Purchase | 2021-02-12 | 13G | Archer Aviation Inc. ACHR | SUVRETTA CAPITAL MANAGEMENT LLC | 2,600,000 5.200% | 2,600,000 (New Position) | Filing History |
| 2021-02-16 4:18 pm Purchase | 2021-02-08 | 13G | Gores Holdings VI, Inc. GHVI | SUVRETTA CAPITAL MANAGEMENT LLC | 2,750,000 8.000% | 2,750,000 (New Position) | Filing History |
| 2021-02-16 3:06 pm Purchase | 2020-12-31 | 13G | JAWS ACQUISITION CORP. JWS | SUVRETTA CAPITAL MANAGEMENT LLC | 4,000,000 5.800% | 500,000 (+14.29%) | Filing History |